Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-SUPREME phase 2 study of ALG-000184 versus tenofovir disoproxil fumarate in treatment-naive chronic hepatitis B
CTR20253117Phase 2Active
- Sponsor
- Aligos Therapeutics
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pevifoscorvir in Chronic Hepatitis B (CHB), sponsored by Aligos Therapeutics. Started Oct 2025; status: active.
02
Drugs
pevifoscorvir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20253117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253117.